Skip to main content
. 2021 Feb;9(4):293. doi: 10.21037/atm-20-6201

Figure 4.

Figure 4

The ROC curve of the nomogram for 3- and 5-year CSS in patients with UAC. (A) 3-year and (B) 5-year ROC curve with internal validation in the development cohort; (C) 3-year and (D) 5-year ROC curve with temporal validation in the verification cohort. ROC, receiver operator characteristic; CSS, cancer-specific survival; UAC, uterine cervical adenocarcinoma.